Published in Open Respir Med J on April 14, 2009
Congestive heart failure: where homeostasis begets dyshomeostasis. J Cardiovasc Pharmacol (2010) 0.88
Severe pulmonary hypertension: The role of metabolic and endocrine disorders. Pulm Circ (2012) 0.87
Skin Involvement and Pulmonary Hypertension Are Associated with Vitamin D Insufficiency in Scleroderma. Int J Mol Sci (2016) 0.75
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med (1999) 82.86
Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell (2008) 5.93
Clinical classification of pulmonary hypertension. J Am Coll Cardiol (2004) 5.87
Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol (2004) 5.79
Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med (1997) 3.91
Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J Bone Miner Res (1993) 3.31
Survival with first-line bosentan in patients with primary pulmonary hypertension. Eur Respir J (2005) 2.83
Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop Relat Res (1998) 2.73
Chronic thromboembolic pulmonary hypertension. Circulation (2006) 2.58
Physical activity and osteoporotic fracture risk in older women. Study of Osteoporotic Fractures Research Group. Ann Intern Med (1998) 2.22
Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Am J Med (1996) 2.08
Costs and quality of life associated with osteoporosis-related fractures in Sweden. Osteoporos Int (2005) 2.05
Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest (2004) 2.00
Severe osteoporosis before and after lung transplantation. Chest (1996) 1.74
Serum levels of parathyroid hormone are related to the mortality and severity of illness in patients in the emergency department. Eur J Clin Invest (1997) 1.54
Genetics of pulmonary hypertension: from bench to bedside. Eur Respir J (2002) 1.50
Osteoporosis in chronic kidney disease. Am J Kidney Dis (2004) 1.29
Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxy vitamin d status, bone mass, and renal function in the frail and very old: a cohort study. J Clin Endocrinol Metab (2004) 1.25
Measurement of quality of life in pulmonary hypertension and its significance. Eur Respir J (2006) 1.23
Prostanoid therapy for pulmonary arterial hypertension. J Am Coll Cardiol (2004) 1.22
Osteoporosis in chronic obstructive pulmonary disease. Eur Respir J Suppl (2003) 1.14
Pulmonary hypertension in peritoneal dialysis patients. Adv Perit Dial (2007) 1.05
Liver disease and osteoporosis. Nutr Clin Pract (2006) 1.02
Osteoporosis before lung transplantation: association with low body mass index, but not with underlying disease. Am J Transplant (2002) 1.02
Severe vitamin D deficiency in Swiss hip fracture patients. Bone (2007) 1.01
Elevated serum parathyroid hormone predicts impaired survival prognosis in a general aged population. Eur J Endocrinol (2008) 0.90
Walking is related to bone density and rates of bone loss. Am J Med (1994) 0.90
Secondary hyperparathyroidism in patients with untreated and treated congestive heart failure. Am J Med Sci (2006) 0.87
Calciotropic hormones and markers of bone remodeling in age-related (type II) femoral neck osteoporosis: alterations consistent with secondary hyperparathyroidism-induced bone resorption. J Gerontol A Biol Sci Med Sci (1997) 0.83
Effects of long-term treatment with loop diuretics on bone mineral density, calcitropic hormones and bone turnover. J Intern Med (2005) 0.82
Bone morphogenetic protein receptor 2 mutations in pulmonary hypertension. Chest (2002) 0.82
Genetic aspects of pulmonary arterial hypertension. Ann Med (2001) 0.81
Pretransplantation bone disease in patients with primary pulmonary hypertension. Chest (2006) 0.79
Osteoporosis is cystic fibrosis. J Cyst Fibros (2003) 0.79
Osteoporosis and inflammatory bowel disease. Am J Gastroenterol (2007) 0.77
Prevention and treatment of osteoporosis in the cystic fibrosis population. J Pediatr Health Care (2001) 0.77
Clinical classification of pulmonary hypertension. J Am Coll Cardiol (2004) 5.87
Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N Engl J Med (2010) 4.36
Inhaled iloprost for severe pulmonary hypertension. N Engl J Med (2002) 3.90
Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA). Circulation (2013) 3.90
Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial. Ann Intern Med (2006) 3.14
Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis. Arthritis Rheum (2007) 3.02
Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit Care Med (2006) 2.77
Impact of thyroid dysfunction on serum cystatin C. Kidney Int (2003) 2.68
Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway. Circ Res (2009) 2.61
Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis. Science (2004) 2.38
Comparison of mycophenolate mofetil and azathioprine for prevention of bronchiolitis obliterans syndrome in de novo lung transplant recipients. Transplantation (2006) 2.07
Uncontrolled arterial hypertension in primary care--patient characteristics and associated factors. Swiss Med Wkly (2012) 2.00
Pancreatic stone protein is highly increased during posttraumatic sepsis and activates neutrophil granulocytes. Crit Care Med (2009) 1.97
Serum creatinine, cystatin C, and beta-trace protein in diagnostic staging and predicting progression of primary nondiabetic chronic kidney disease. Clin Chem (2010) 1.95
Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation (2011) 1.92
Deliberate removal of T cell help improves virus-neutralizing antibody production. Nat Immunol (2004) 1.90
Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy. Clin Infect Dis (2004) 1.89
Graft-versus-leukemia reactions in allogeneic chimeras. Blood (2003) 1.84
Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months. Kidney Int (2008) 1.84
Safety and efficacy of exercise training in various forms of pulmonary hypertension. Eur Respir J (2012) 1.83
Daytime Cheyne-Stokes respiration in ambulatory patients with severe congestive heart failure is associated with increased mortality. Chest (2007) 1.73
The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles. Proc Natl Acad Sci U S A (2005) 1.71
Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: a randomized controlled trial. Am J Respir Crit Care Med (2011) 1.71
Increased regulatory and decreased CD8+ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension. Respiration (2007) 1.67
Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases. Arthritis Rheum (2005) 1.64
A novel hierarchical prognostic model of AML solely based on molecular mutations. Blood (2012) 1.64
Genetic deletion of p66(Shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress. Proc Natl Acad Sci U S A (2007) 1.63
Martorell hypertensive ischemic leg ulcer: a model of ischemic subcutaneous arteriolosclerosis. Arch Dermatol (2010) 1.55
Optimal preprocedural platelet transfusion threshold for central venous catheter insertions in patients with thrombocytopenia. Transfusion (2011) 1.52
Inhibition of fibroblast activation protein and dipeptidylpeptidase 4 increases cartilage invasion by rheumatoid arthritis synovial fibroblasts. Arthritis Rheum (2010) 1.52
Gene regulatory control of myocardial energy metabolism predicts postoperative cardiac function in patients undergoing off-pump coronary artery bypass graft surgery: inhalational versus intravenous anesthetics. Anesthesiology (2007) 1.51
Infarct-remodelled hearts with limited oxidative capacity boost fatty acid oxidation after conditioning against ischaemia/reperfusion injury. Cardiovasc Res (2012) 1.51
Finding the right position: a three-year, single-center experience with the "self-locating" catheter. Perit Dial Int (2010) 1.49
Current understanding of the metabolism and biological actions of HDL. Curr Opin Clin Nutr Metab Care (2005) 1.45
Falsely positive dexamethasone suppression test in a patient treated with phenytoin to prevent seizures due to nocardia brain abscesses. Swiss Med Wkly (2002) 1.42
Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension. Am J Respir Crit Care Med (2004) 1.40
Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection. AIDS (2007) 1.39
Efficacy and Safety of Long-Term Imatinib Therapy for Pulmonary Arterial Hypertension. Respiration (2015) 1.39
The influences of hyperprolactinaemia and obesity on cardiovascular risk markers: effects of cabergoline therapy. Clin Endocrinol (Oxf) (2006) 1.38
Microparticles as mediators of cellular cross-talk in inflammatory disease. Autoimmunity (2006) 1.38
Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis. Eur J Immunol (2011) 1.37
Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein. Circulation (2005) 1.36
Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and sterile vascular inflammation in atherosclerosis. Nat Immunol (2013) 1.36
The two faces of the 15-lipoxygenase in atherosclerosis. Prostaglandins Leukot Essent Fatty Acids (2007) 1.35
Age- and gender-related prevalence of multimorbidity in primary care: the Swiss FIRE project. BMC Fam Pract (2012) 1.31
Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: a novel, early, and sensitive marker of acute coronary syndromes. Eur Heart J (2007) 1.31
High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease. Curr Opin Lipidol (2004) 1.30
Serum cystatin C is sensitive to small changes in thyroid function. Clin Chim Acta (2003) 1.24
Possibilities and limitations of a miniaturized long-term extracorporeal life support system as bridge to transplantation in a case with biventricular heart failure. Interact Cardiovasc Thorac Surg (2008) 1.20
Personal best time, not anthropometry or training volume, is associated with total race time in a triple iron triathlon. J Strength Cond Res (2011) 1.20
Deoxysphingoid bases as plasma markers in diabetes mellitus. Lipids Health Dis (2010) 1.20
Selective arterial calcium stimulation and hepatic venous sampling in the evaluation of hyperinsulinemic hypoglycemia: potential and limitations. J Vasc Interv Radiol (2004) 1.19
Microparticles stimulate the synthesis of prostaglandin E(2) via induction of cyclooxygenase 2 and microsomal prostaglandin E synthase 1. Arthritis Rheum (2007) 1.17
Extralymphatic virus sanctuaries as a consequence of potent T-cell activation. Nat Med (2007) 1.17
Monitoring of ventilation during exercise by a portable respiratory inductive plethysmograph. Chest (2005) 1.16
Right heart assessment by echocardiography: gender and body size matters. J Am Soc Echocardiogr (2012) 1.14
Determinants of endothelial function in patients with COPD. Eur Respir J (2013) 1.13
Second allograft for hematologic relapse of acute leukemia after first allogeneic stem-cell transplantation from related and unrelated donors: the role of donor change. J Clin Oncol (2013) 1.13
Reference values for the 6-minute walk test in healthy children and adolescents in Switzerland. BMC Pulm Med (2013) 1.12
Intra- and inter-judge reliabilities in measuring the skin-fold thicknesses of ultra runners under field conditions. Percept Mot Skills (2010) 1.12
Significant reduction of red blood cell transfusion requirements by changing from a double-unit to a single-unit transfusion policy in patients receiving intensive chemotherapy or stem cell transplantation. Haematologica (2011) 1.11
Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use. Drug Alcohol Depend (2005) 1.09
Sex difference in open-water ultra-swim performance in the longest freshwater lake swim in Europe. J Strength Cond Res (2013) 1.09
MicroRNA-18a enhances the interleukin-6-mediated production of the acute-phase proteins fibrinogen and haptoglobin in human hepatocytes. J Biol Chem (2011) 1.09
High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation. Lipids Health Dis (2013) 1.08
Prognostic value of monosomal karyotype in comparison to complex aberrant karyotype in acute myeloid leukemia: a study on 824 cases with aberrant karyotype. Blood (2011) 1.08
Antibiotics in acute non-pneumonic lower-respiratory tract infection. Lancet Infect Dis (2013) 1.08
The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis. Arthritis Rheum (2008) 1.08
Expression and function of EZH2 in synovial fibroblasts: epigenetic repression of the Wnt inhibitor SFRP1 in rheumatoid arthritis. Ann Rheum Dis (2011) 1.08
Glutathione S-transferase genotypes modify lung function decline in the general population: SAPALDIA cohort study. Respir Res (2007) 1.06
Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients. Nephrol Dial Transplant (2006) 1.06
Passive pulmonary hypertension: more than hydrostatics. Chest (2014) 1.05
Ethnicity-dependent genetic association of ABCA2 with sporadic Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet (2006) 1.05
Effects of long-term continuous positive airway pressure on body composition and IGF1. Eur J Endocrinol (2010) 1.05
Nuclear factor I revealed as family of promoter binding transcription activators. BMC Genomics (2011) 1.04
The FIRE project: a milestone for research in primary care in Switzerland. Swiss Med Wkly (2011) 1.03
Inflammatory cytokines in pulmonary hypertension. Respir Res (2014) 1.03
Ganciclovir/valganciclovir prophylaxis decreases cytomegalovirus-related events and bronchiolitis obliterans syndrome after lung transplantation. Clin Infect Dis (2008) 1.03
Lung transplantation for lymphangioleiomyomatosis: the European experience. J Heart Lung Transplant (2009) 1.03
Osteoporosis before lung transplantation: association with low body mass index, but not with underlying disease. Am J Transplant (2002) 1.02
Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosis. Arthritis Rheum (2009) 1.01
Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosis. Haematologica (2010) 1.01
Soluble klotho and autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol (2011) 1.00